 |
市场调查报告书
商品编码
1608872
糖尿病照护市场：依产品类型（血糖监测设备、胰岛素帮浦）、以糖尿病类型、依最终使用者、按地区Diabetes Care Market, By Product Type (Glucose Monitoring Devices, Insulin Pumps, By Diabetes Type, By End User, By Geography |
||||||
糖尿病照护市场预计到2024年将达到316.9亿美元，预计到2031年将达到568.6亿美元，2024年至2031年的复合年增长率为8.7%。
| 分析范围 | 分析详情 | ||
|---|---|---|---|
| 基准年 | 2023年 | 市场规模（2024年） | 316.9亿美元 |
| 实际资料 | 2019-2023 | 预测期 | 2024-2031 |
| 预测期复合年增长率（2024-2031） | 8.70% | 预计金额（2031年） | 568.6亿美元 |
糖尿病是一种慢性代谢疾病，影响身体利用葡萄糖的方式。诊断患有糖尿病的人数每年都在稳定增加。根据国际糖尿病联盟2022年7月的数据，2021年将有超过5.37亿成年人患有糖尿病，预计2045年将增加至7亿。这种疾病的日益普及增加了全球对糖尿病照护产品和服务的需求。糖尿病照护市场包括血糖值监测设备（如血糖仪、试纸、采血针和监测系统）、胰岛素输送设备（如胰岛素笔、帮浦和注射器）以及糖尿病管理应用程式和软体。
市场动态：
全球糖尿病照护市场的成长是由糖尿病患者数量的增加、糖尿病自我管理意识的提高、糖尿病管理技术的进步以及政府遏製糖尿病负担的倡议所推动的。然而，高昂的设备成本、许多国家有限的医疗报销以及某些设备读数不准确的风险正在限制市场成长。同时，自动调节血糖值的人工胰腺装置的市场开拓、口服胰岛素製剂的持续研发以及胰岛细胞移植正在为市场创造利润丰厚的机会。
本研究的主要特点
该报告对全球糖尿病护理市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
根据公司亮点、产品系列、主要亮点、绩效和策略等参数对全球糖尿病护理市场的主要企业进行了分析。
主要公司包括 Medtronic、Abbott、Pumps It, Inc.、Embecta Corp.、Insulet Corporation、Ypsomed AG、Roche AG、Tandem Diabetes Care, Inc.、Terumo、Novo Nordisk A/S、SOOIL Developments Co. Ltd.。 ViCentra BV、CeQur Corporation、Dexcom, Inc. 等。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
全球糖尿病护理市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
透过用于分析全球糖尿病照护市场的各种策略矩阵，将有助于相关人员做出决策。
目录
第一章 分析目的与前提
- 分析目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
第三章市场动态、法规与趋势分析
- 市场动态
- 影响分析
- 主要亮点
- 监管场景
- 产品发布/核准
- PEST分析
- 波特的分析
- 企业合併(M&A) 场景
- 流行病学
- 市场趋势
第 4 章 全球糖尿病照护市场：按产品类型划分，2019-2031 年（十亿美元）
- 血糖监测装置
- 胰岛素帮浦
- 贴片帮浦
- 繫绳帮浦
- 植入式胰岛素泵
- 其他（胰岛素注射器、笔针等）
第五章 全球糖尿病照护市场：依糖尿病类型划分，2019-2031 年（十亿美元）
- 2型糖尿病
- 1型糖尿病
- 其他（如妊娠糖尿病）
第六章 全球糖尿病照护市场：以最终用户划分，2019-2031 年（十亿美元）
- 医院/诊所
- 居家医疗
- 门诊就诊环境
- 其他（学术研究机构、临床实验室等）
第七章 全球糖尿病照护市场：按地区划分，2019-2031 年（十亿美元）
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第八章 竞争格局
- Medtronic
- Abbott
- Pumps It, Inc.
- Embecta Corp
- Insulet Corporation
- Ypsomed AG
- Roche AG
- Tandem Diabetes Care, Inc.
- Terumo
- Novo Nordisk A/S
- SOOIL Developments Co., Ltd
- Microtec Medical Ltd
- ViCentra BV
- CeQur Corporation
- Dexcom, Inc.
第九章 分析师建议
- 《命运之轮》
- 分析师观点
- Coherent Opportunity Map (COM)
第10章 参考文献与调查方法
- 参考
- 分析方法
- 关于相干市场洞察
The diabetes care market is estimated to be valued at USD 31.69 billion in 2024 and is expected to reach USD 56.86 billion by 2031, exhibiting a compound annual growth rate (CAGR) of 8.7% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | 31.69 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 8.70% | 2031 Value Projection: | 56.86 Bn |
Diabetes is a chronic metabolic disease that affects how the body utilizes glucose. The number of people diagnosed with diabetes has been steadily increasing over the years. In July 2022, according to the International Diabetes Federation, over 537 million adults were living with diabetes in 2021 which is projected to grow to 700 million by 2045. The rising prevalence of the disease has led to an increased demand for diabetes care products and services globally. The diabetes care market covers blood glucose monitoring devices like glucometers, test strips, lancets and monitoring systems, insulin delivery devices like insulin pens, pumps, and injectors, and diabetes management apps and software.
Market Dynamics:
The global diabetes care market growth is driven by the growing diabetes patient pool, increasing awareness about diabetes self-management, advancement of diabetes management technologies, and government initiatives to curb the burden of the disease. However, high device costs, limited medical reimbursement in many countries, and risk of inaccurate readings with some devices restrain the market growth. On the other hand, development of artificial pancreas devices that automatically regulate blood glucose levels, ongoing R&D to develop oral insulin formulations, and islet cell transplantations create lucrative opportunities in the market.
Key Features of the Study:
This report provides in-depth analysis of the global diabetes care market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global diabetes care market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Medtronic, Abbott, Pumps It, Inc., Embecta Corp, Insulet Corporation, Ypsomed AG, Roche AG, Tandem Diabetes Care, Inc., Terumo, Novo Nordisk A/S, SOOIL Developments Co., Ltd, Microtec Medical Ltd, ViCentra B.V., CeQur Corporation, and Dexcom, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global diabetes care market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diabetes care market
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2019 - 2031)
- Glucose Monitoring Devices
- Blood glucose monitoring (BGM)
- Continuous glucose monitoring (CGM)
- Flash glucose monitoring (FGM)
- Insulin Pumps
- Patch pump
- Tethered pump
- Implanted insulin pump
- Others (Insulin Syringes, Pen Needles, etc.)
- Diabetes Type Insights (Revenue, USD Bn, 2019 - 2031)
- Type 2 Diabetes
- Type 1 Diabetes
- Other (Gestational Diabetes, etc.)
- End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals & Clinics
- Homecare Settings
- Ambulatory Care Settings
- Others (Academic and Research Institutes, Clinical Laboratories, etc.)
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Medtronic
- Abbott
- Pumps It, Inc.
- Embecta Corp
- Insulet Corporation
- Ypsomed AG
- Roche AG
- Tandem Diabetes Care, Inc.
- Terumo
- Novo Nordisk A/S
- SOOIL Developments Co., Ltd
- Microtec Medical Ltd
- ViCentra B.V.
- CeQur Corporation
- Dexcom, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Diabetes Care Market, By Product Type
- Diabetes Care Market, By Diabetes Type
- Diabetes Care Market, By End User
- Diabetes Care Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Epidemiology
- Market Trends
4. Global Diabetes Care Market, By Product Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Glucose Monitoring Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Blood glucose monitoring (BGM)
- Continuous glucose monitoring (CGM)
- Flash glucose monitoring (FGM)
- Insulin Pumps
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Patch pump
- Tethered pump
- Implanted insulin pump
- Others (Insulin Syringes, Pen Needles, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Diabetes Care Market, By Diabetes Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Type 2 Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Type 1 Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Other (Gestational Diabetes, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Diabetes Care Market, By End User, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Ambulatory Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others (Academic and Research Institutes, Clinical Laboratories, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Diabetes Care Market, By Region, 2019 - 2031, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Diabetes Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Diabetes Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Diabetes Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Diabetes Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Diabetes Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Diabetes Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pumps It, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Embecta Corp
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Insulet Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ypsomed AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Tandem Diabetes Care, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Terumo
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novo Nordisk A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- SOOIL Developments Co., Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Microtec Medical Ltd
- ViCentra B.V.
- CeQur Corporation
- Dexcom, Inc.
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
